Association between nonalcoholic fatty liver disease and dietary inflammation index and its practical significance

Guo Yan; Huang Li; Yang GuoChao; Liu Shan; Du LinNa; Wang MinJuan

doi:10.3969/j.issn.1001-5256.2019.10.042

Volume 35 Issue 10

Oct. 2019

Turn off MathJax

Article Contents

Article Navigation > Journal of Clinical Hepatology > 2019 > 35(10): 2324-2326

PDF( 1896 KB)

Association between nonalcoholic fatty liver disease and dietary inflammation index and its practical significance

DOI: 10.3969/j.issn.1001-5256.2019.10.042

Xi'an Medical University，Department of General Medicine,The First Affiliated Hospital of Xi'an Medical University

Received Date: 2019-05-05
Published Date: 2019-10-20

Abstract

Abstract

In recent years,the incidence rate of nonalcoholic fatty liver disease(NAFLD) keeps increasing,and the age of onset gradually becomes younger. Unhealthy lifestyle,including bad dietary choices,is one of the major causes of NAFLD. However,there are still no clear treatment regimens for NAFLD,and lifestyle intervention with the aim of weight loss is still the most mature method for the treatment of NAFLD. Studies have shown that chronic inflammatory response runs through the whole process of the development and progression of NAFLD,and diet plays an important role in the development and regulation of inflammatory cascade. Dietary inflammation index(DII) is an effective tool for assessing inflammatory potential in individual dietary structure,and since its development,it has been continuously improved and is now widely used in the clinical research on many diseases. This article discusses the association between NAFLD and DII,in order to achieve primary prevention of NAFLD from dietary structure and reduce the incidence rate of NAFLD.
- non-alcoholic fatty liver disease,
- dietary inflammation index,
- inflammation,
- diet therapy

FullText(HTML)

References(36)

References

[1] ALISI A,CARPINO G,OLIVEIRA FL,et al. The role of tissue macrophage-mediated inflammation on NAFLD pathogenesis and its clinical implications[J]. Mediators Inflamm,2017,2017:8162421.

[2] FENG G,NIU CY. Advances in the treatment of nonalcoholic fatty liver disease[J]. J Clin Hepatol,2017,33(12):2433-2438.(in Chinese)冯巩,牛春燕.非酒精性脂肪性肝病的治疗进展[J].临床肝胆病杂志,2017,33(12):2433-2438.

[3] RINELLA ME. Nonalcoholic fatty liver disease:A systematic review[J]. JAMA,2015,313(22):2263-2273.

[4] DIEHL AM,DAY C. Cause,Pathogenesis,and treatment of nonalcoholic steatohepatitis[J]. N Engl J Med,2017,377(21):2063-2072.

[5] YOUNOSSI ZM,KOENIG AB,ABDELATIF D,et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes[J]. Hepatology,2016,64(1):73-84.

[6] ZHU JZ,ZHOU QY,WANG YM,et al. Prevalence of fatty liver disease and the economy in China:A systematic review[J].World J Gastroenterol,2015,21(18):5695-5706.

[7] WONG VW,CHAN WK,CHITTURI S,et al. Asia-Pacific Working Party on non-alcoholic fatty liver disease guidelines2017-Part 1:Definition,risk factors and assessment[J]. J Gastroenterol Hepatol,2018,33(1):70-85.

[8] BOUZIANAS DG,BOUZIANA SD,HATZITOLIOS AI. Potential treatment of human nonalcoholic fatty liver disease with longchain omega-3 polyunsaturated fatty acids[J]. Nutr Rev,2013,71(11):753-771.

[9] BUZZETTI E,PINZANI M,TSOCHATZIS EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease(NAFLD)[J]. Metabolism,2016,65(8):1038-1048.

[10] RAMALLAL R,TOLEDO E,MARTNEZ JA,et al. Inflammatory potential of diet,weight gain,and incidence of overweight/obesity:The SUN cohort[J]. Obesity(Silver Spring),2017,25(6):997-1005.

[11] HAAS JT,FRANCQUE S,STAELS B. Pathophysiology and mechanisms of nonalcoholic fatty liver disease[J]. Annu Rev Physiol,2016,78:181-205.

[12] AHLUWALIA N,ANDREEVA VA,KESSE-GUYOT E,et al.Dietary patterns,inflammation and the metabolic syndrome[J]. Diabetes Metab,2013,39(2):99-110.

[13] PARK SY,KANG M,WILKENS LR,et al. The dietary inflammatory index and all-cause,cardiovascular disease,and cancer mortality in the multiethnic cohort study[J]. Nutrients,2018,10(12):1844.

[14] SHIVAPPA N,STECK SE,HUSSEY JR,et al. Inflammatory potential of diet and all-cause,cardiovascular,and cancer mortality in National Health and Nutrition Examination Survey III Study[J]. Eur J Nutr,2017,56(2):683-692.

[15] SHIVAPPA N,STECK SE,HURLEY TG,et al. Designing and developing a literature-derived,population-based dietary inflammatory index[J]. Public Health Nutr,2014,17(8):1689-1696.

[16] HBERT JR,SHIVAPPA N,WIRTH MD,et al. Perspective:The dietary inflammatory index(DII)-lessons learned,improvements made,and future directions[J]. Adv Nutr,2019,10(2):185-195.

[17] SHIVAPPA N,HBERT JR,POLESEL J,et al. Inflammatory potential of diet and risk for hepatocellular cancer in a case-control study from Italy[J]. Br J Nutr,2016,115(2):324-331.

[18] WANG XY,FANG AP,CHEN PY,et al. High dietary inflammatory index scores are associated with an elevated risk of hepatocellular carcinoma in a case-control study[J]. Food Funct,2018,9(11):5832-5842.

[19] SHIVAPPA N,HBERT JR,STECK SE,et al. Dietary inflammatory index and odds of colorectal cancer in a case-control study from Iran[J]. Asian Pac J Cancer Prev,2018,19(7):1999-2006.

[20] SHIVAPPA N,HBERT JR,JALILPIRAN Y,et al. Association between dietary inflammatory index and prostate cancer in Shiraz province of Iran[J]. Asian Pac J Cancer Prev,2018,19(2):415-420.

[21] SHIVAPPA N,HBERT JR,PADDOCK LE,et al. Dietary inflammatory index and ovarian cancer risk in a New Jersey case-control study[J]. Nutrition,2018,46:78-82.

[22] FRITH E,SHIVAPPA N,MANN JR,et al. Dietary inflammatory index and memory function:Population-based national sample of elderly Americans[J]. Br J Nutr,2018,119(5):552-558.

[23] HUANG WQ,MO XF,YE YB,et al. A higher Dietary Inflammatory Index score is associated with a higher risk of breast cancer among Chinese women:A case-control study[J]. Br J Nutr,2017,117(10):1358-1367.

[24] SHIVAPPA N,GODOS J,HBERT JR,et al. Dietary inflammatory index and cardiovascular risk and mortality—a Metaanalysis[J]. Nutrients,2018,10(2):200.

[25] NAMAZI N,LARIJANI B,AZADBAKHT L. Dietary inflammatory index and its association with the risk of cardiovascular diseases,metabolic syndrome,and mortality:A systematic review and Meta-analysis[J]. Horm Metab Res,2018,50(5):345-358.

[26] O'NEIL A,SHIVAPPA N,JACKA FN,et al. Pro-inflammatory dietary intake as a risk factor for CVD in men:A 5-year longitudinal study[J]. Br J Nutr,2015,114(12):2074-2082.

[27] SAGHAFI-ASL M,AMIRI P,NAGHIZADEH M,et al. Association of endotoxaemia with serum free fatty acids in metabolically healthy and unhealthy abdominally obese individuals:A case-control study in northwest of Iran[J]. BMJ Open,2017,7(5):e015910.

[28] NEUFCOURT L,ASSMANN KE,FEZEU LK,et al. Prospective association between the dietary inflammatory index and metabolic syndrome:Findings from the SU. VI. MAX study[J].Nutr Metab Cardiovasc Dis,2015,25:988-996.

[29] BERGHEIM I,WEBER S,VOS M,et al. Antibiotics protect againstfructose-induced hepatic lipid accumulation in mice:Role of endotoxin[J]. J Hepatol,2008,48(6):983-992.

[30] MAZIDI M,SHIVAPPA N,WIRTH MD,et al. Diet with greater inflammatory potential is associated with higher prevalence of fatty liver among US adults[J]. Eur J Clin Nutr,2018.[Epub ahead of print]

[31] RYAN MC,ITSIOPOULOS C,THODIS T,et al. The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease[J]. J Hepatol,2013,59(1):138-143.

[32] CANTERO I,ABETE I,BABIO N,et al. Dietary Inflammatory index and liver status in subjects with different adiposity levels within the PREDIMED trial[J]. Clin Nutr,2018,37(5):1736-1743.

[33] European Association for the Study of the Liver(EASL),European Association for the Study of Diabetes(EASD),European Association for the Study of Obesity(EASO). EASL-EASDEASO clinical practice guidelines for the management of nonalcoholic fatty liver disease[J]. J Hepatol,2016,64(6):1388-1402.

[34] ZELBER-SAGI S,SALOMONE F,MLYNARSKY L. The Mediterranean dietary pattern as the diet of choice for NAFLD; evidence and plausible mechanisms[J]. Liver Int,2017,37(7):936-949.

[35] LEONI S,TOVOLI F,NAPOLI L,et al. Current guidelines for the management of non-alcoholic fatty liver disease:A systematic review with comparative analysis[J]. World J Gastroenterol,2018,24(30):3361-3373.

[36] NIU HY,LI H,DING YP. Advances in the treatment of nonalcoholic fatty liver disease[J]. J Clin Hepatol,2018,34(2):433-437.(in Chinese)牛海艳,李海,丁玉平.非酒精性脂肪性肝病的治疗进展[J].临床肝胆病杂志,2018,34(2):433-437.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (1104) PDF downloads(247)

Association between nonalcoholic fatty liver disease and dietary inflammation index and its practical significance

DOI: 10.3969/j.issn.1001-5256.2019.10.042

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Association between nonalcoholic fatty liver disease and dietary inflammation index and its practical significance

DOI: 10.3969/j.issn.1001-5256.2019.10.042

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content